EP2900269
Samsetning af regórafeníbi og asetýlsalisýlsýru til að meðhöndla krabbamein í ristli og endaþarmi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.9.2013EP published:
1.8.2018EP application number:
13770659.4
EP translation filed:
19.9.2018Grant published:
15.10.2018EPO information:
European Patent Register
Max expiry date:
22.9.2033Expiry date:
22.9.2025
Title:
COMBINATION OF REGORAFENIB AND ACETYLSALICYLIC ACID FOR TREATING COLORECTAL CANCER
Timeline
Today
23.9.2013EP application
1.8.2018EP Publication
19.9.2018Translation submitted
15.10.2018Registration published
22.9.2025Expires
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353, Berlin, DE
Name:
BAYER AGAddress:
51368, Leverkusen, DE
Inventor
Name:
WEBER, OlafAddress:
Wülfrath, DE
Name:
ZIEGELBAUER, KarlAddress:
Haan, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
12185852Date:
25.9.2012Country:
EP
Classification
Categories:
A61K 45/06, A61K 31/4412, A61K 31/616, A61P 35/00, A61P 35/04, A61K 31/44
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 4.9.2018
Expires: 22.9.2019
Payer: Árnason Faktor
Number: 7
Paid: 27.8.2019
Expires: 22.9.2020
Payer: Árnason Faktor
Number: 8
Paid: 25.8.2020
Expires: 22.9.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.8.2021
Expires: 22.9.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 30.8.2022
Expires: 22.9.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 31.8.2023
Expires: 22.9.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 23.8.2024
Expires: 22.9.2025
Payer: Árnason Faktor ehf.